Adam Lezack - 13 Jan 2026 Form 4 Insider Report for Beta Bionics, Inc. (BBNX)

Role
Director
Signature
/s/ Stephen Feider, Attorney-in-Fact
Issuer symbol
BBNX
Transactions as of
13 Jan 2026
Net transactions value
$0
Form type
4
Filing time
14 Jan 2026, 20:30:06 UTC
Previous filing
02 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lezack Adam Director C/O BETA BIONICS, INC., 11 HUGHES, IRVINE /s/ Stephen Feider, Attorney-in-Fact 14 Jan 2026 0002048466

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BBNX Common Stock Award $0 +3,997 +47% $0.000000 12,432 13 Jan 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan.